FRIDAY, DECEMBER 9, 2016

Human challenge study to accelerate dengue vaccine development

Researchers recently conducted a controlled human challenge study that suggests an experimental dengue vaccine can give healthy volunteers full protection, urging experts to use this evidence to accelerate the development of a dengue vaccine. Read More »

Immune system's elasticity is demonstrated in Virginia Tech study

A team from the Virginia Tech Carilion Research Institute recently conducted a study of the long-term memory of the human immune system that may allow the manipulation of the system into fighting specific illnesses. Read More »

Two new studies explore containment options for camel-transmitted MERS

While camels are useful and beloved creatures, they also harbor the ability to transmit to humans communicable forms of MERS coronavirus. Read More »

Buffalo researcher explores attitudes and emotions surrounding Ebola

Janet Ying, of the University of Buffalo, is leading a study that suggests there is more to Ebola than illness: tangled in the matrices of disease and prevention is perception of risk and risk’s influence on emotion and behavior. Read More »

Resources sought for HIV vaccine research

The HIV Vaccine Program Management Office (HIVV PMO) and the Walter Reed Army Institute of Research (WRAIR) recently announced they are asking companies, educational institutions, organizations, and consortia for information about clinical research support. Read More »

Virginia's low-income HIV patients benefit from Affordable Care Act

A recent study conducted by the University of Virginia School of Medicine shows that the Virginia’s HIV patients benefit from the Affordable Care Act. Read More »

Cirrhosis antibodies heighten poor outcome risk for autoimmune hepatitis patients

A recent study shows that cirrhosis at first diagnosis as well as antibodies used to treat soluble liver antigen/liver pancreas antigen (SLA/LP) both increase the risks of poor outcomes, short-term and long-term, for patients who have autoimmune hepatitis. Read More »

ADMA Biologics receives patent for immunodeficiency treatment

ADMA Biologics, Inc., a late-stage biopharmaceutical company, said Monday it has received a patient for its treatment of immunodeficiency. Read More »

IDT Biologika purchases Gallant Custom Laboratories

IDT Biologika recently announced that it has acquired Gallant Custom Laboratories, an autogenous vaccine manufacturer located in Ontario, Canada. Read More »

Studying wildlife may help understanding of human antibiotic resistance

A team of scientists from Virginia Tech recently reported that studying the lifestyle differences between wildlife species may help researchers better understand how antibiotic resistance works and spreads. Read More »

21st Century Cures Act risks public health

According to the National Vaccine Information Center (NVIC), a nonprofit organization, the proposed H4 6 or 21st Century Cures Act places public health at risk by lowering the licensing standards of the U.S. Federal Drug Administration (FDA). Read More »

Whooping cough vaccine available at all Wash. Rite Aids

As whooping cough cases continue to rise, retailer encourages everyone to get vaccinated. Read More »

Officials give update on southeastern Indiana HIV outbreak

Indiana State Department of Health (ISDH) officials provided an update this week about the HIV outbreak taking place in southeastern Indiana. Read More »

North American birds contract and spread highly contagious avian flu

Recent analysis shows North America birds have contracted and spread highly contagious strains of avian influenza (HPAI) H5 viruses that originated in Eurasia and continue to spread around the world. Read More »

Walgreens Flu Index for week of Feb. 23

Walgreens released its latest flu index for the week of February 23 today. Read More »